key: cord-0988732-j9be6occ authors: Yang, Pu; Wang, Xia; Liu, Pin; Wei, Cong; He, Bingyan; Zheng, Junwen; Zhao, Dongchi title: Clinical characteristics and risk assessment of newborns born to mothers with COVID-19 date: 2020-06-30 journal: Journal of Clinical Virology DOI: 10.1016/j.jcv.2020.104356 sha: f85ea2217aa44f2b595142465c2dfd41bb15dab9 doc_id: 988732 cord_uid: j9be6occ Abstract Background Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is causing an outbreak of pneumonia in Wuhan, Hubei Province, China, and other international areas. Objective Here, we report the clinical characteristics of the newborns delivered by SARS-CoV-2 infected pregnant women. Methods We prospectively collected and analyzed the clinical features, laboratory data and outcomes of 7 newborns delivered by SARS-CoV-2 infected pregnant women in Zhongnan Hospital of Wuhan University during January 20 to January 29, 2020. Results 4 of the 7 newborns were late preterm with gestational age between 36 weeks and 37 weeks, and the other 3 were full-term infants. The average birth weight was 2096 ± 660 g. All newborns were born without asphyxia. 2 premature infants performed mild grunting after birth, but relieved rapidly with non-invasive continuous positive airway pressure (nCPAP) ventilation. 3 cases had chest X-ray, 1 was normal and 2 who were supported by nCPAP presented mild neonatal respiratory distress syndrome (NRDS). Samples of pharyngeal swab in 6 cases, amniotic fluid and umbilical cord blood in 4 cases were tested by qRT-PCR, and there was no positive result of SARS-CoV-2 nucleic acid in all cases. Conclusions The current data show that the infection of SARS-CoV-2 in late pregnant women does not cause adverse outcomes in their newborns, however, it is necessary to separate newborns from mothers immediately to avoid the potential threats. T 2. Methods From January 20 to January 29, 2020, 7 newborns delivered by pregnant women infected with SARS-CoV-2 in late pregnancy in Zhongnan Hospital of Wuhan University, were admitted. All of the pregnant women received the cesarean section. 4 cases received cesarean section to prevent the uncertain transmission to newborns when infection symptoms appeared. 2 received emergency cesarean section for hypertension and blurred vision caused by severe preeclampsia. 1 who was asymptomatic at delivery and febrile 2 days later, received cesarean section because of severely elevated aminotransferase. After delivery, 5 newborns were immediately transferred to negative pressure ward (−10 Pa) of neonatal intensive care unit (NICU) for isolation and observation, the other 2 were cared by healthy family members at the request of guardian, separating from their mothers. All 7 newborns were tested for SARS-CoV-2 nucleic acid after birth. Delivery history, neonatal birth status including Apgar score, clinical features, blood tests, as well as nucleic acid detection of amniotic fluid, umbilical cord blood and neonatal pharyngeal swabs were collected. The potential influence of newborns and risk assessment of mother-to-child transmission were analyzed. Data are shown as mean ± standard deviation. Umbilical cord blood, amniotic fluid and pharyngeal swabs were collected immediately(< 30 min) after delivery in isolation operating room, all the samples were sealed up in sampling bottles, then were sent to the P3 Laboratory in Zhongnan Hospital of Wuhan University for nucleic acid extraction and qRT-PCR test. After given Apgar score, the newborns(5 cases) were either transferred to NICU negative pressure isolation ward for treatment within 10 min or transferred to obstetrical ward for isolation and was cared by healthy family members (2 cases, including 1 case that didn't perform nucleic acid test). The parturients were transferred to the infectious isolation ward for postoperative rehabilitation. The newborns transferred to NICU were further isolated in neonatal incubator and monitored continuously. Blood gas analysis, complete blood count, biochemical profile and coagulation test were performed. During the isolation period, the breathing, heart rate, feeding, response and laboratory results of the newborns were recorded continuously. Antibiotics were not used unless there are signs of bacterial infection during hospitalization. Pharyngeal swabs were collected for a second SARS-CoV-2 nucleic acid test 2−5 days after birth. Newborns showed 2 consecutive negative results for virus nucleic acid and with good condition in the following 7 days were permitted to be discharged, and continued with home quarantine and telephone follow-up. Amniotic fluid, umbilical cord blood and pharyngeal swabs were collected within 5 min after delivery. One of the parturients was diagnosed as COVID-19 two days after delivery, amniotic fluid and umbilical cord blood of the newborn were not obtained. The collection of blood and pharyngeal swabs in newborns in NICU was carried out under the protection of class II. All the blood samples and pharyngeal swabs were placed in the required cell-culture medium and delivered to Laboratory P3 within 30 min. According to the testing guidelines of China Center for Disease Control and prevention [8] , SARS-CoV-2 was tested by 2019 novel coronavirus (ORF1ab/N gene) nucleic acid detection kit (BioGerm Medical Technology Company, Shanghai, China).The fluorescence quantitative RT-PCR (qRT-PCR) test was completed according to the instructions of the kit. Informed consents of the routine treatment and specimen's collection were signed by the guardian of newborns and kinsfolk of the pregnant women. This study was approved by the Medical Ethical Committee of Zhongnan Hospital of Wuhan University (clinical ethical approval number 2020004) A total of 7 pregnant women with SARS-CoV-2 infection in late pregnancy were included in the study. Except case 1, who presented fever 2 days after delivery, the remaining 6 had onset symptoms of infection 1-6 days before delivery. The main clinical manifestations are fever, cough and other respiratory symptoms, followed by abdominal pain, diarrhea and other gastrointestinal symptoms. All seven women delivered by cesarean section, 4 were monitored by the obstetricians before onset of labor, then received cesarean section to prevent the uncertain transmission to newborns when infection symptoms appeared. 2 received emergency cesarean section for hypertension and blurred vision caused by severe preeclampsia to prevent the uncertain transmission to newborns. Among the 7 cases, 6 showed signs of viral pneumonia by chest CT after the symptoms of infection ( Fig. 1) , and 1 didn't show typical pathological signs in chest CT scan (Table 1) . The 7 newborns delivered by SARS-CoV-2 infected mothers are either late preterm infants with gestational age(GA)between 36 weeks and 37weeks(4 cases) or full term infants (3 cases), with an average birth weight of 2096 ± 660 g (1880−3800 g), without birth asphyxia (Apgar scores of 1 min and 5 min ≥ 8) ( Table 2 ). The appearance of the newborns was normal, with the skin color being ruddy, and with normal limb tension. Among the 5 neonates admitted to NICU, 2 premature infants performed mild respiratory distress manifestation of grunting after birth, but relieved rapidly with non-invasive continuous positive airway pressure(nCPAP) ventilation. The other 3 cases showed no signs of dyspnea and hypoxia. 3 cases accepted chest X-ray, 1 was normal and 2 who were supported by nCPAP presented mild neonatal respiratory distress syndrome (NRDS). 2 newborns who were not admitted to NICU were taken home by their healthy family members for isolation care at the request of their guradians. Through daily telephone follow-up, we obtained the performance of the newborns and provided families with nursing guidance, and advised that once the infants performed poor reaction or milk rejection, they should return to the NICU immediately. Blood test results of 1 h and 48 h are shown in Table 3 . The white blood cell count(WBC), neutrophil count ratio(NEU%) and lymphocyte count ratio (LYM%) were normal. As for procalcitonin (PCT), only 1 case increased slightly, while the others were normal or physiologically increased. C-reactive protein (CRP) results were normal for all newborns at birth and the following days. The blood biochemical results showed that the AST increased in 2 cases on the day of birth, and the AST decreased significantly in 1 case after 48 h of reexamination. The other case didn't collect the second blood test due to the discharged from the hospital on the second day after birth at the request of family members. The myocardial globin (MYO) and creatine kinase isoenzyme MB (CK-MB) were increased in 5 neonates, and there was no abnormality in electrocardiograph (ECG) test. As for D-dimer (DD), case 5 and case 7 were in the normal range, the other 3 cases were all increased. And all of the results of blood bacterial cultures were negative. Three newborns received chest X-ray, one was normal and two presented mild neonatal respiratory distress syndrome (Fig. 2) . qRT-PCR results showed that among the 6 neonates, 4 did not detect SARS-CoV-2 nucleic acid fragments in amniotic fluid, cord blood and pharyngeal swabs at birth, and the pharyngeal swabs were also negative within 5 days. Two cases only with pharyngeal swabs detection were also negative. Among 5 neonates admitted to the NICU, 2 premature infants were given nCPAP treatment due to signs of mild respiratory distress after birth, 3 did not receive respiratory support or oxygen therapy. 4 newborns were given piperacillin tazobactam for empiric anti-infection treatment, while the others were only given feeding and nursing care. None of the neonates received any antiviral treatment. In final, all of the 7 newborns were discharged without aggravation during hospitalization and isolated at home (including 2 who were not admitted to the NICU), their performance was normal according to telephone followup. By March 5, 2020, the number of confirmed cases has reached 80552, with 3042 deaths in China [9] . Confirmed cases have also been found in many other countries, the outbreak has rapidly spread to 78 coutries worldwide out of China, and it is predictable that the number of infected people will continue to increase exponentially with the change of diagnostic criteria [10] . As of February 26, 2020, near six hundred cases of infection in children have been reported in China [4] .Pregnant women are at high risk of SARS-CoV-2 infection [5, 6] , and are prone to serious complications after SARS-like virus infection. Accurate data on maternal infection are not available, but the inevitable risk of childbirth and maternal infection poses a serious challenge to medical institutions during the high prevalence season. Therefore, it is imperative to evaluate the risk of infected mothers to their babies. In this group of data, most pregnant women with SARS-CoV-2 infection showed symptoms of infection before delivery. As little is known to the virus at the early stage of outbreak, most of the newborns were born by planned cesarean delivery to prevent transmission to newborns. Two newborns were separated from their mothers after birth and taken home by healthy family members at their request. 5 newborns were admitted to the NICU, of which 2 newborns developed mild respiratory distress after birth, and were given nCPAP-assisted ventilation.3 newborns had stable breathing and didn't require any respiratory support. All newborns were not treated with any antiviral drugs. The newborns that stayed in NICU had no abnormal signs during the monitoring of breathing, heart rate, and oxygen saturation. There was no abnormal manifestation in digestion, urination, defecation, and mental reactions during hospitalization. Complete blood counts taken on the first and third day of birth did not indicate obvious abnormal, all indicators were consistent with the normal range of newborns of the same gestational age and same day of age. Some newborns' MYO and CK-MB were higher than normal values. Coagulation indexes showed that some neonatal D-dimers were higher than normal values. Although Shek and colleagues have reported that SARS-CoV cannot be transmitted from infected mothers to newborns [11] , it can aggravate the clinical outcomes of mothers and newborns. Our observation demonstrated that the condition of infants was not aggravated after their exposure to SARS-CoV-2 infected mothers, and we have also commented that compared to infected adults, the condition of infected children is significantly milder, with faster recovery, shorter virus shedding time and better prognosis [7] . However, one newborn in our department who was born to mother with suspected COVID-19 presented hematochezia recently, so it is still necessary to accumulate more clinical data for further understanding of maternal infection's influence on the newborn. We understand some limitations in this study. For example, after 5 neonates were admitted to the NICU, no progressive exacerbation was found, so we didn't perform chest X-ray examination for all of them. In addition, the number of cases was limited, and the observation time was short. Despite of this, we should strengthen the monitoring of mother-to-child transmission, and further accumulation and detailed research are still needed. In summary, the current data demonstrate that late pregnant women with COVID-19 does not cause severe adverse events on their newborns in this small series. In spite of this, newborns are still at high risk of COVID-19 in condition of postnatal infection without rigorous nosocomial infection control. It is necessary to separate newborns from mothers immediately to avoid the potential threats. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors The authors have indicated they have no potential conflicts of interest to disclose. Sex male male female male male female female Gestational age 37w+2 38w+2 36w+2 36w+3 36w 36w+2 38w Birthweight, g 2870 3730 1880 3040 3800 2620 2800 1' Apgar score 8 9 8 8 8 9 World Health Organization: Statement on the second meeting of the International Health Regulations, Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV) National Health Commission of People's Republique of China: Diagnosis, Treatment and Prevention Program of coronavirus disease (COVID-19 Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy Corona Virus Disease 2019, a growing threat to children? National Health Commission of People's Republique of China: Daily briefing on novel coronavirus cases in China Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Infants born to mothers with severe acute respiratory syndrome Chest X-ray images of 2 premature newborns with NRDS Chest X-ray images of 2 premature newborns (A, case 3, B, case 4) who showed mild respiratory distress at birth showing bilateral ground-glass opacities, granular high density shadows We acknowledge all health-care workers involved in the outbreak of COVID-19 in Wuhan and other areas. We thank Prof.